Our previous study had demonstrated that Hsp–Cu(II) reduced fast blood glucose and lipid levels in the T2DM model mice by improving hepatic glucose metabolism through suppression of gluconeogenesis and promotion of glycogen synthesis [27]. Here, HSP90B2P is linked to type 2 diabetes mellitus.